Mohr K - Search Results

1

Kostenis E, Mohr K. Kostenis E, et al. Among authors: mohr k. Dtsch Med Wochenschr. 1994 Aug 26;119(34-35):1173-4. doi: 10.1055/s-0029-1235090. Dtsch Med Wochenschr. 1994. PMID: 8076506 German. No abstract available.

2

Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation.

Kostenis E, Mohr K. Kostenis E, et al. Among authors: mohr k. Trends Pharmacol Sci. 1996 Aug;17(8):280-3. doi: 10.1016/0165-6147(96)10034-1. Trends Pharmacol Sci. 1996. PMID: 8810873 Review.

3

Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria.

Maass A, Kostenis E, Mohr K. Maass A, et al. Among authors: mohr k. Eur J Pharmacol. 1995 Jan 5;272(1):103-6. doi: 10.1016/0014-2999(94)00664-s. Eur J Pharmacol. 1995. PMID: 7713140

4

Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors.

Botero Cid MH, Holzgrabe U, Kostenis E, Mohr K, Tränkle C. Botero Cid MH, et al. Among authors: mohr k. J Med Chem. 1994 May 13;37(10):1439-45. doi: 10.1021/jm00036a008. J Med Chem. 1994. PMID: 8182702

5

Search for lead structures to develop new allosteric modulators of muscarinic receptors.

Tränkle C, Kostenis E, Burgmer U, Mohr K. Tränkle C, et al. Among authors: mohr k. J Pharmacol Exp Ther. 1996 Nov;279(2):926-33. J Pharmacol Exp Ther. 1996. PMID: 8930201

6

Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.

Tränkle C, Kostenis E, Mohr K. Tränkle C, et al. Among authors: mohr k. Naunyn Schmiedebergs Arch Pharmacol. 2001 Aug;364(2):172-8. doi: 10.1007/s002100100441. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11534857

7

Structure-activity relationships in a series of bisquaternary bisphthalimidine derivatives modulating the muscarinic M(2)-receptor allosterically.

Botero Cid HM, Tränkle C, Baumann K, Pick R, Mies-Klomfass E, Kostenis E, Mohr K, Holzgrabe U. Botero Cid HM, et al. Among authors: mohr k. J Med Chem. 2000 Jun 1;43(11):2155-64. doi: 10.1021/jm991136e. J Med Chem. 2000. PMID: 10841794

8

Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors.

Kostenis E, Botero Cid HM, Holzgrabe Y, Mohr K. Kostenis E, et al. Among authors: mohr k. Eur J Pharmacol. 1996 Oct 31;314(3):385-92. doi: 10.1016/s0014-2999(96)00568-7. Eur J Pharmacol. 1996. PMID: 8957263

9

Variation of the oxime function of bispyridinium-type allosteric modulators of M2-cholinoceptors.

Gasteiger J, Holzgrabe U, Kostenis E, Mohr K, Sürig U, Wagener M. Gasteiger J, et al. Among authors: mohr k. Pharmazie. 1995 Feb;50(2):99-105. Pharmazie. 1995. PMID: 7700977

10

Muscarinic allosteric modulators: atypical structure-activity-relationships in bispyridinium-type compounds.

Sürig U, Gaal K, Kostenis E, Tränkle C, Mohr K, Holzgrabe U. Sürig U, et al. Among authors: mohr k. Arch Pharm (Weinheim). 2006 Apr;339(4):207-12. doi: 10.1002/ardp.200600005. Arch Pharm (Weinheim). 2006. PMID: 16572483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters